Contract 75P00220F80003
Mylan Specialty Lp · Department Of Health And Human Services · December 17, 2025
Mylan Specialty Lp was awarded a federal contract by Department Of Health And Human Services (Office Of The Assistant Secretary For Administration) on December 17, 2025 for $286,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Basking Ridge, NJ. This is a task or delivery order issued under parent IDIQ V797P2070D. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $286,000.
Contract details
- PIID
- 75P00220F80003
- Parent IDIQ
- V797P2070D
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Basking Ridge, NJ
- First action
- December 17, 2025
Description
CLOSEOUT - CONTRACT #V797P-2070D/75P00220F80003
Modification timeline
-
December 17, 2025Mod P00001 · Close Out$286.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75P00220F80003?
Contract 75P00220F80003 is a federal contract awarded to Mylan Specialty Lp by Department Of Health And Human Services on December 17, 2025 for $286,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75P00220F80003?
Mylan Specialty Lp won contract 75P00220F80003 from Department Of Health And Human Services.
How much is contract 75P00220F80003 worth?
Contract 75P00220F80003 has obligated $0 to date but carries a potential ceiling of $286,000 if fully funded and all options are exercised.